The chance of receiving protective antibodies after covid-19 vaccination is increased by delaying the treatment with b-cell depleters (Ocrevus and kesimpta),

1 bookmarks
Custom sorting
The chance of receiving protective antibodies after covid-19 vaccination is increased by delaying the treatment with b-cell depleters (Ocrevus and kesimpta),
The chance of receiving protective antibodies after covid-19 vaccination is increased by delaying the treatment with b-cell depleters (Ocrevus and kesimpta),
January 13, 2022Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?AbstractAlthough there
·disorders.solutions·
The chance of receiving protective antibodies after covid-19 vaccination is increased by delaying the treatment with b-cell depleters (Ocrevus and kesimpta),